David A. Stamler

This profile gathers the share dealings of David A. Stamler across 2 companies, led by Xenoport Inc and Auspex Pharmaceuticals, Inc. Between 14 January 2009 and 5 May 2015, the trades on record add up to 15 filings.

Sales make up the whole of the open-market record (4 sales, €345k). Outside the open market, there are 4 share grants and 6 option exercises. In 2015 alone, the filings show no purchases and 2 sales.

The latest filing, published on 6 May 2015, reports a transaction in Auspex Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.